ONEMEDNET CORPORATION Crypto Asset Realized And Unrealized Loss Nonoperating
ONEMEDNET CORPORATION (ONMD) reported Crypto Asset Realized And Unrealized Loss Nonoperating of $50.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Other Income
us-gaap:CryptoAssetRealizedAndUnrealizedLossNonoperating · last filed 2026-08-14
- ONEMEDNET CORPORATION crypto asset realized and unrealized loss nonoperating for the quarter ending 2026-06-30 was $50.00K, a 83.33% decline year-over-year.
- ONEMEDNET CORPORATION crypto asset realized and unrealized loss nonoperating for the quarter ending 2026-03-31 was $200.00K, a 60.00% decline year-over-year.
- ONEMEDNET CORPORATION crypto asset realized and unrealized loss nonoperating for the quarter ending 2025-09-30 was $100.00K, a 96.08% increase year-over-year.
- ONEMEDNET CORPORATION crypto asset realized and unrealized loss nonoperating for the quarter ending 2025-06-30 was $300.00K.
- ONEMEDNET CORPORATION crypto asset realized and unrealized loss nonoperating for fiscal 2024 was $100.00K.
| Period end | Crypto Asset Realized And Unrealized Loss Nonoperating 3 month | Crypto Asset Realized And Unrealized Loss Nonoperating 6 month | Crypto Asset Realized And Unrealized Loss Nonoperating 9 month | Crypto Asset Realized And Unrealized Loss Nonoperating 12 month |
|---|---|---|---|---|
| 2026-06-30 | $50.00K 10-Q · filed 2026-08-14 | $200.00K 10-Q · filed 2026-08-14 | ||
| 2026-03-31 | $200.00K S-1/A · filed 2026-07-08 | |||
| 2025-09-30 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $400.00K derived: sum of 2 quarters · filed 2025-11-14 | $900.00K 10-Q · filed 2025-11-14 | $949.00K derived: sum of 4 quarters · filed 2025-11-14 |
| 2025-06-30 | $300.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $800.00K 10-Q · filed 2025-08-13 | $849.00K derived: sum of 3 quarters · filed 2025-08-13 | $900.00K derived: sum of 4 quarters · filed 2025-08-13 |
| 2025-03-31 | $500.00K 10-Q · filed 2025-05-14 | $549.00K derived: sum of 2 quarters · filed 2025-05-14 | $600.00K derived: sum of 3 quarters · filed 2025-05-14 | |
| 2024-12-31 | $49.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $100.00K derived: sum of 2 quarters · filed 2025-04-15 | $100.00K 10-K · filed 2025-04-15 | |
| 2024-09-30 | $51.00K 10-Q · filed 2024-12-17 | $51.00K 10-Q · filed 2024-12-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |